Home/Filings/4/0001643074-16-000003
4//SEC Filing

Axovant Sciences Ltd. 4

Accession 0001643074-16-000003

CIK 0001636050operating

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 10:11 AM ET

Size

5.2 KB

Accession

0001643074-16-000003

Insider Transaction Report

Form 4
Period: 2016-03-10
Altmeyer Mark
Pres&Chief Commercial Officer
Transactions
  • Purchase

    Common Shares

    2016-03-10$11.14/sh+2,300$25,6222,300 total
Footnotes (1)
  • [F1]The price reported represents the weighted average price of shares acquired in multiple transactions at prices ranging from $11.10 to $11.17 per share, inclusive. The Reporting Person will provide, upon request of the staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares acquired at each separate price.

Issuer

Axovant Sciences Ltd.

CIK 0001636050

Entity typeoperating

Related Parties

1
  • filerCIK 0001636050

Filing Metadata

Form type
4
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 10:11 AM ET
Size
5.2 KB